Ident. | Authors (with country if any) | Title |
---|
000013 (2019) |
Manas K. Akmatov [Allemagne] ; Peggy Riese [Allemagne] ; Stephanie Trittel [Allemagne] ; Marcus May [Allemagne] ; Jana Prokein [Allemagne] ; Thomas Illig [Allemagne] ; Christoph Schindler [Allemagne] ; Carlos A. Guzmán [Allemagne] ; Frank Pessler [Allemagne] | Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly. |
000025 (2019) |
Micha Loebermann [Allemagne] ; Carlos Fritzsche [Allemagne] ; Hilte Geerdes-Fenge [Allemagne] ; Esther Heijnen [Pays-Bas] ; Daniel Kirby [États-Unis] ; Emil C. Reisinger [Allemagne] | A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. |
000044 (2018) |
Cornelia Betsch [Allemagne] ; Constanze Rossmann [Allemagne] ; Mathias W. Pletz [Allemagne] ; Horst C. Vollmar [Allemagne] ; Antje Freytag [Allemagne] ; Ole Wichmann [Allemagne] ; Regina Hanke [Allemagne] ; Wolfgang Hanke [Allemagne] ; Dorothee Heinemeier [Allemagne] ; Philipp Schmid [Allemagne] ; Sarah Eitze [Allemagne] ; Winja Weber [Allemagne] ; Anne Reinhardt [Allemagne] ; Nora K. Küpke [Allemagne] ; Christina Forstner [Allemagne, Autriche] ; Carolin Fleischmann-Struzek [Allemagne] ; Anna Mikolajetz [Allemagne] ; Josephine Römhild [Allemagne] ; Julia Neufeind [Allemagne] ; Thorsten Rieck [Allemagne] ; Kasia Suchecka [Allemagne] ; Konrad Reinhart [Allemagne] | Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60. |
000045 (2018) |
Roman Prymula [République tchèque] ; Dorothee Kieninger [Allemagne] ; Emmanuel Feroldi [France] ; Emilia Jordanov [États-Unis] ; Siham B'Chir [France] ; Xavier Dacosta [États-Unis] | Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic. |
000047 (2018) |
A. Möhl [Allemagne] ; L. Gr Fe [Allemagne] ; C. Helmeke [Allemagne] ; D. Ziehm [Allemagne] ; M. Monazahian [Allemagne] ; H-M Irmscher [Allemagne] ; J. Dreesman [Allemagne] | Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016. |
000048 (2017) |
S. Petersen ; H. Roggendorf [Allemagne] ; S. Wicker | [Vaccine Preventable Diseases: Knowledge, Attitudes and Vaccination Status of Medical Students]. |
000049 (2017) |
Bernd Salzberger [Allemagne] ; Florian Hitzenbichler [Allemagne] ; Michael Reng [Allemagne] ; Gabriele Birkenfeld [Allemagne] | [It's still time to get the Flu vaccine for this season]. |
000093 (2016) |
Ahmed Mostafa [Allemagne, Égypte] ; El-Sayed M. Abdelwhab [Allemagne] ; Heiko Slanina [Allemagne] ; Mohamed A. Hussein [Égypte] ; Irina Kuznetsova [Allemagne] ; Christian G. Schüttler [Allemagne] ; John Ziebuhr [Allemagne] ; Stephan Pleschka [Allemagne] | Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains. |
000095 (2016) |
Ulrich Behre [Allemagne] ; Olivier Van Der Meeren [Belgique] ; Priya Crasta [Inde] ; Linda Hanssens [Belgique] ; Narcisa Mesaros [Belgique] | Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. |
000097 (2016) |
Jakob P. Cramer [Allemagne] ; Katrin Dubischar [Autriche] ; Susanne Eder [Autriche] ; Gerd D. Burchard [Allemagne] ; Tomas Jelinek [Allemagne] ; Bernd Jilma [Autriche] ; Herwig Kollaritsch [Autriche] ; Emil Reisinger [Allemagne] ; Kerstin Westritschnig [Autriche] | Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. |
000103 (2016) |
Christiaan Dolk [Pays-Bas] ; Martin Eichner [Allemagne] ; Robert Welte [Allemagne] ; Anastassia Anastassopoulou [Allemagne] ; Laure-Anne Van Bellinghen [Belgique] ; Barbara Poulsen Nautrup [Allemagne] ; Ilse Van Vlaenderen [Belgique] ; Ruprecht Schmidt-Ott [Allemagne, Belgique] ; Markus Schwehm [Allemagne] ; Maarten Postma [Pays-Bas] | Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. |
000129 (2015) |
B A Lehmann [Pays-Bas] ; R A C. Ruiter [Pays-Bas] ; D. Van Dam [Pays-Bas] ; S. Wicker [Allemagne] ; G. Kok [Pays-Bas] | Sociocognitive predictors of the intention of healthcare workers to receive the influenza vaccine in Belgian, Dutch and German hospital settings. |
000149 (2015) |
Cornelius Remschmidt [Allemagne] ; Thorsten Rieck [Allemagne] ; Birte Bödeker [Allemagne] ; Ole Wichmann [Allemagne] | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. |
000162 (2014) |
Markus A. Rose ; Oliver Damm ; Wolfgang Greiner ; Markus Knuf ; Peter Wutzler ; Johannes G. Liese ; Hagen Krüger ; Ulrich Wahn ; Tom Schaberg ; Markus Schwehm ; Thomas F. Kochmann ; Martin Eichner [Allemagne] | The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. |
000166 (2014) |
C. Sengler [Allemagne] ; M. Niewerth ; T. Kallinich ; A. Nimtz-Talaska ; M. Haller ; H-I Huppertz ; K. Minden | Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases. |
000181 (2014) |
Birte Bödeker [Allemagne] ; Dietmar Walter [Allemagne] ; Sabine Reiter [Allemagne] ; Ole Wichmann [Allemagne] | Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. |
000202 (2013) |
Peter Wutzler ; Roland Hardt ; Markus Knuf ; Klaus Wahle | Targeted vaccine selection in influenza vaccination. |
000210 (2013) |
Ulrich Zimmermann [Allemagne] ; Gaëtan Gavazzi ; Patrick Richard ; Cécile Eymin ; Benoît Soubeyrand ; Martine Baudin | Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. |
000220 (2013) |
G. Falkenhorst [Allemagne] ; T. Harder ; C. Remschmidt ; M. Terhardt ; F. Zepp ; T. Ledig ; S. Wicker ; B. Keller-Stanislawski ; T. Mertens | Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany. |
000235 (2012) |
Mathieu Peeters [Belgique] ; Stefan Regner ; Tejaswini Vaman ; Jeanne-Marie Devaster ; Lars Rombo | Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. |
000251 (2012) |
Cynthia Nassim [États-Unis] ; Shane Christensen ; Dan Henry ; Sandra Holmes ; Matthew Hohenboken ; Niranjan Kanesa-Thasan | Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. |